Volume 12, Issue 1 (Volume 12, No 1 2021)
jdc 2021, 12(1): 3-10 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hosseini H, Firooz R, Firooz A. COVID-19 and dermatologists (5). jdc 2021; 12 (1) :3-10
URL: http://jdc.tums.ac.ir/article-1-5511-en.html
URL: http://jdc.tums.ac.ir/article-1-5511-en.html
1- Center for Research and Training in Skin Diseases and Leprosy,Tehran University of Medical Sciences, Tehran, Iran
2- Center for Research and Training in Skin Diseases and Leprosy,Tehran University of Medical Sciences, Tehran, Iran ,alifiruz@yahoo.com
2- Center for Research and Training in Skin Diseases and Leprosy,Tehran University of Medical Sciences, Tehran, Iran ,
Abstract: (2074 Views)
The fifth paper of reviews on COVID-19 addresses COVID-19 vaccines, as vaccination has started in the world and Iran. In this paper, we review different types of available vaccines and also various platforms for production of COVID-19 vaccines as well as the vaccines produced in each platform in the world and Iran. Then the considerations about vaccination in patients with skin diseases, specially those using immunomodulator drugs will be presented. Finally, the cutaneous adverse effects of COVID-19 vaccines will be reviewed.
Type of Study: Review |
Subject:
Special
Received: 2021/06/2 | Accepted: 2021/05/5 | Published: 2021/05/5
Received: 2021/06/2 | Accepted: 2021/05/5 | Published: 2021/05/5
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
